Comparative efficacy of tandem autologous versus autologous followed by allogeneic hematopoietic cell transplantation in patients with newly diagnosed multiple myeloma: a systematic review and meta-analysis of randomized controlled trials

被引:0
作者
Mohamed A Kharfan-Dabaja
Mehdi Hamadani
Tea Reljic
Taiga Nishihori
William Bensinger
Benjamin Djulbegovic
Ambuj Kumar
机构
[1] H. Lee Moffitt Cancer Center/University of South Florida College of Medicine,Blood and Marrow Transplantation Program
[2] American University of Beirut Medical Center,Bone Marrow Transplantation Program, Department of Internal Medicine, Division of Hematology
[3] West Virginia University,Oncology
[4] University of South Florida,Osborn Hematopoietic Malignancy and Transplantation Program
[5] Morsani College of Medicine,Center for Evidence
[6] University of Washington School of Medicine and Fred Hutchinson Cancer Center,Based Medicine and Health Outcomes Research
[7] Moffitt Cancer Center,Department of Medicine, Division of Oncology
[8] Moffitt Cancer Center,Department of Health Outcomes and Behavior
来源
Journal of Hematology & Oncology | / 6卷
关键词
Autologous hematopoietic stem cell transplantation; Allogeneic hematopoietic stem cell transplantation; Multiple myeloma; Systematic review;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 277 条
[1]  
Attal M(1996)A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe francais du myelome N Engl J Med 335 91-97
[2]  
Harousseau JL(2008)Improved survival in multiple myeloma and the impact of novel therapies Blood 111 2516-2520
[3]  
Stoppa AM(2003)A phase 2 study of bortezomib in relapsed, refractory myeloma N Engl J Med 348 2609-2617
[4]  
Sotto JJ(2002)Immunomodulatory drug CC-5013 overcomes drug resistance and is well tolerated in patients with relapsed multiple myeloma Blood 100 3063-3067
[5]  
Fuzibet JG(1999)Antitumor activity of thalidomide in refractory multiple myeloma N Engl J Med 341 1565-1571
[6]  
Rossi JF(1999)Total therapy with tandem transplants for newly diagnosed multiple myeloma Blood 93 55-65
[7]  
Casassus P(2003)Single versus double autologous stem-cell transplantation for multiple myeloma N Engl J Med 349 2495-2502
[8]  
Maisonneuve H(2009)Tandem versus single autologous hematopoietic cell transplantation for the treatment of multiple myeloma: a systematic review and meta-analysis J Natl Cancer Inst 101 100-106
[9]  
Facon T(2002)Improved outcome of allogeneic transplantation in high-risk multiple myeloma patients after nonmyeloablative conditioning J Clin Oncol 20 1295-1303
[10]  
Ifrah N(2001)Progress in allogenic bone marrow and peripheral blood stem cell transplantation for multiple myeloma: a comparison between transplants performed 1983–93 and 1994–8 at European group for blood and marrow transplantation centres Br J Haematol 113 209-216